Jade Oliveira, Nathalia Sernizon Guimarães, Analupe Webber, Keila Seabra Teles Ferreira, George Kroumpouzos, Gisele Viana de Oliveira
{"title":"Picosecond Laser Therapy for Traumatic and Surgical Scars: a Systematic Review.","authors":"Jade Oliveira, Nathalia Sernizon Guimarães, Analupe Webber, Keila Seabra Teles Ferreira, George Kroumpouzos, Gisele Viana de Oliveira","doi":"10.1016/j.clindermatol.2026.10.008","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2026.10.008","url":null,"abstract":"<p><strong>Background: </strong>Traumatic and surgical scars may cause functional impairment, cosmetic concerns, and reduced quality of life. This review evaluated the effectiveness and safety of picosecond laser therapy for traumatic and surgical scars.</p><p><strong>Methods: </strong>we conducted a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement. PubMed, Scopus, Web of Science, Embase, Cochrane Library, MEDLINE, LILACS, and VERTINDEX were searched from inception through August 2025 without language or date restrictions; database alerts were monitored through December 2025. Clinical studies evaluating picosecond laser therapy for non-acne traumatic or surgical scars were included. Risk of bias in randomized trials was assessed using RoB 2.</p><p><strong>Results: </strong>13 studies (446 patients, 475 scars), including five randomized controlled studies, met eligibility criteria. Most studies showed improvement in validated scar scales, global aesthetic assessments, and objective measures. Controlled trials generally favored picosecond laser therapy over untreated controls and showed advantages over fractional carbon dioxide laser for selected outcomes, although superiority was not consistent across all domains. Four randomized studies were judged to have some concerns and one was at high overall risk of bias. Adverse events were predominantly mild and transient, with no serious or permanent events.</p><p><strong>Conclusions: </strong>current evidence supports picosecond laser therapy as a promising and generally well-tolerated option for traumatic and surgical scars. However, heterogeneity in scar characteristics, treatment protocols, and outcome measures.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149215126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"AI-Powered Prescribing in Dermatology and Its Clinical Opportunities, Risks, and Ethical Considerations.","authors":"Mohamad Goldust, Jane M Grant-Kels","doi":"10.1016/j.clindermatol.2026.10.007","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2026.10.007","url":null,"abstract":"","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149191873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Beyond Legal Compliance: Ethical Obligations for Lactation Accommodations in Dermatology Residency.","authors":"Gabriella Resnick, Shari R Lipner","doi":"10.1016/j.clindermatol.2026.10.006","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2026.10.006","url":null,"abstract":"<p><p>Women now comprise the majority of dermatology residents, and residency training coincides with a childbearing timeline that residents do not control. Federal legal and national accreditation frameworks establish meaningful minimum standards for lactation accommodations. Yet compliance with these standards does not guarantee that accommodations function in practice. The central ethical failure is not scheduling conflicts that inevitably arise and interfere with the usage of such accommodations, but the absence of a functional process through which a resident can flag that an accommodation is not working under real clinical conditions. Closing this gap between policy and practice requires shared responsibility: residents communicating needs proactively, and programs providing confidential, non-evaluative structures for residents to voice their needs. When responsibility is shared rather than individually absorbed, dermatology residency programs honor the ethical principles of autonomy, beneficence, non-maleficence, and justice.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jacob Beer, Tanya Boghosian, Mohamad Goldust, Jane M Grant-Kels, Marina Landua
{"title":"From Empiricism to Precision: Century of Paradigm Shifts in Medical Dermatology.","authors":"Jacob Beer, Tanya Boghosian, Mohamad Goldust, Jane M Grant-Kels, Marina Landua","doi":"10.1016/j.clindermatol.2026.10.005","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2026.10.005","url":null,"abstract":"<p><p>Over the past century, advances in scientific understanding and therapeutic development have fundamentally reshaped dermatology. Diseases once managed with empiric, toxic, or largely ineffective treatments can now be approached with therapies that target specific pathways, achieve sustained disease control, and, in some cases, alter prognosis. Herein, we reviewed landmark therapeutic advances across infectious, inflammatory, autoimmune, vascular, and oncologic dermatology, focusing on interventions that changed the standard of care or substantially improved patient outcomes. Transformative advances include penicillin for syphilis, isotretinoin for severe acne, biologics for psoriasis, corticosteroids and rituximab for pemphigus vulgaris, targeted biologic and Janus kinase inhibitors for inflammatory and autoimmune diseases, beta-blockers for infantile hemangiomas, immunotherapy and targeted therapy for cutaneous malignancies, and Hedgehog pathway inhibitors for advanced basal cell carcinoma. Collectively, these breakthroughs expanded what treatment could achieve, from curing previously chronic infection and controlling severe inflammatory disease to restoring hair or pigmentation and prolonging survival in advanced malignancy. Progress arose through both sustained research into disease biology and unexpected clinical observations that opened new therapeutic possibilities. These landmark therapeutic breakthroughs trace dermatology's evolution from empiric treatment toward increasingly precise, mechanism-based care. This history illustrates how scientific discovery and clinical observation can redefine the management and prognosis of dermatologic disease.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Metabolic-Dermatologic Axis: GLP-1/GIP Agonists as Emerging Immunometabolic Therapies for Obesity-Associated Skin Disease.","authors":"Fabio Biondi, Giulia Veneziano, Stefania Guida, Franco Rongioletti","doi":"10.1016/j.clindermatol.2026.09.040","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2026.09.040","url":null,"abstract":"<p><p>Obesity is increasingly recognized as a systemic determinant of dermatologic disease rather than merely a comorbidity accompanying skin disorders. Excess adiposity promotes insulin resistance, adipose-tissue dysfunction, chronic low-grade inflammation, altered immune responses, vascular abnormalities, mechanical stress, and impaired tissue repair, thereby influencing the development and severity of inflammatory and metabolic dermatoses. Psoriasis, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), acanthosis nigricans, intertriginous disease, and impaired wound healing exemplify conditions in which metabolic and cutaneous pathways are closely interconnected. This relationship provides the biological basis for the concept of a metabolic-dermatologic axis, in which adipose tissue, systemic metabolism, immune activation, and cutaneous inflammation interact bidirectionally.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149168545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Benjamin D Hu, Courtney A Chau, Sabrina Ghalili, Kristina Navrazhina, Emma Guttman-Yassky, Helen He
{"title":"Cutaneous Effects and Aesthetic Management of Glucagon-like Peptide-1 Receptor Agonists: A Narrative Review.","authors":"Benjamin D Hu, Courtney A Chau, Sabrina Ghalili, Kristina Navrazhina, Emma Guttman-Yassky, Helen He","doi":"10.1016/j.clindermatol.2026.09.041","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2026.09.041","url":null,"abstract":"<p><p>Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are among the most widely prescribed medications in the United States, with expanding indications beyond type-2 diabetes mellitus to include obesity, cardiovascular risk reduction, and metabolic dysfunction-associated steatohepatitis. As their utilization increases, the dermatologic effects of these agents become increasingly relevant to clinical practice. This narrative review examines the cutaneous effects of GLP-1RAs across six domains: facial volume loss and accelerated skin aging, changes in hair density, wound healing, striae distensae and body skin laxity, cutaneous adverse events, and emerging therapeutic benefits in inflammatory skin disease. Herein, we review proposed mechanisms and evidence-based management strategies for each domain, including biostimulatory fillers, energy-based devices, nutritional optimization, and pharmacologic interventions. Prospective, large-scale clinical studies are needed to clarify mechanisms of GLP-1RA modulation in skin and to guide management of these AEs as next-generation agents enter clinical practice.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"\"Ozempic Face\" and Facial Aging.","authors":"Sam Fathizadeh, Angelina S Hwang, Elika Hoss","doi":"10.1016/j.clindermatol.2026.10.004","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2026.10.004","url":null,"abstract":"<p><p>The widespread adoption of glucagon-like peptide-1 (GLP-1) receptor agonists has introduced a growing clinical challenge for dermatologists and cosmetic practitioners: managing the facial changes associated with rapid weight loss. The term \"Ozempic face\" has entered popular vocabulary to describe the appearance of accelerated facial aging in patients on these medications, characterized by volume deflation, skin laxity, and loss of structural support. This review examines the anatomical and histological basis of these changes, with attention to the roles of dermal white adipose tissue (dWAT), skeletal remodeling, and sarcopenia. We discuss the clinical presentation of weight-loss-associated facial change and outline a practical framework for patient assessment and counseling. The timing and sequencing of interventions across the weight loss journey are addressed, with emphasis on a health-first approach that prioritizes tissue preservation. As GLP-1 receptor agonists expand into new therapeutic indications, including inflammatory skin diseases, dermatology clinicians are uniquely positioned to counsel and manage patients experiencing these changes.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Military shaving waivers for pseudofolliculitis barbae: Ethical considerations for dermatologists.","authors":"Geat Ramush, Jinho Kim, Shari R Lipner","doi":"10.1016/j.clindermatol.2026.10.003","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2026.10.003","url":null,"abstract":"<p><p>Pseudofolliculitis barbae (PFB) is a chronic inflammatory disorder triggered by shaving and disproportionately affects individuals of African descent. For service members, medically appropriate management may conflict with military grooming standards requiring a clean-shaven appearance. Recent policy changes have placed greater restrictions on shaving waivers and may create career consequences for service members who continue to require accommodations despite treatment. These policies raise ethical concerns involving justice, beneficence, nonmaleficence, and autonomy. Military safety requirements related to protective equipment must be balanced against the clinical needs of patients with PFB. Laser hair removal may provide meaningful benefit but can recur, permanently alter facial hair growth, and carry additional risks depending on skin type, device selection, and treatment setting. Dermatologists should provide accurate medical assessments, support medically necessary accommodations, and use shared decision-making so that treatment remains guided by clinical need and patient preference rather than institutional pressure.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149147888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Military shaving waivers for pseudofolliculitis barbae: Ethical considerations for dermatologists.","authors":"Geat Ramush, Jinho Kim, Shari R Lipner","doi":"10.1016/j.clindermatol.2026.10.002","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2026.10.002","url":null,"abstract":"<p><p>Pseudofolliculitis barbae (PFB) is a chronic inflammatory disorder triggered by shaving and disproportionately affects individuals of African descent. For service members, medically appropriate management may conflict with military grooming standards requiring a clean-shaven appearance. Recent policy changes have tightened restrictions on shaving waivers and may create career consequences for service members who still require accommodations despite treatment. These policies raise ethical concerns involving justice, beneficence, nonmaleficence, and autonomy. Military safety requirements related to protective equipment must be balanced against the clinical needs of patients with PFB. Laser hair removal may provide meaningful benefit but can recur, permanently alter facial hair growth, and carry additional risks depending on skin type, device selection, and treatment setting. Dermatologists should provide accurate medical assessments, support medically necessary accommodations, and use shared decision-making so that treatment remains guided by clinical need and patient preference rather than institutional pressure.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149135174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Danielle M Khalilzadeh, Timothy Klufas, Albert E Zhou, Jane M Grant-Kels
{"title":"The Ethical and Practical Issues of Market Exclusivity for Naturally Derived Dermatologic Medications: The Case of Cantharidin.","authors":"Danielle M Khalilzadeh, Timothy Klufas, Albert E Zhou, Jane M Grant-Kels","doi":"10.1016/j.clindermatol.2026.10.001","DOIUrl":"https://doi.org/10.1016/j.clindermatol.2026.10.001","url":null,"abstract":"<p><p>New dermatologic therapies derived from long-used natural substances can enter the market at prices far above previously available compounded or imported formulations, once they receive United States Food and Drug Administration (FDA) approval. Patent protection is often blamed for this shift, but the mechanism at work, in most cases, is FDA-granted market exclusivity, a distinct incentive that can apply even to substances too old to be patented. Herein, we examine how this incentive structure has affected access to cantharidin, a naturally derived agent long used to treat verrucae and molluscum contagiosum, following its formal FDA approval. We outline the ethical tensions this type of scenario raises for physicians trying to balance beneficence, non-maleficence, autonomy, and justice. Rather than a blanket exception for compounding, targeted evidence-based reforms are proposed that could preserve incentives for genuine innovation while protecting patient access and distributive justice.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149104994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}